Overview

Luspatercept in Patients Affected With Rare Inherited Anemias

Status:
NOT_YET_RECRUITING
Trial end date:
2029-09-30
Target enrollment:
Participant gender:
Summary
This is a prospective multicenter phase II basket trial evaluating Luspatercept in patients affected with rare inherited anemias
Phase:
PHASE2
Details
Lead Sponsor:
EuroBloodNet Association
Treatments:
luspatercept